XPH | State Street SPDR S&P Pharmaceuticals ETFAMEXETF golden cross and death cross projections, cross tests and history

$64.30
+$0.69 (+1.08%)

State Street SPDR S&P Pharmaceuticals ETF (XPH) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $64.30 vs 50 $66.26 / 200 $61.82
Projection
No cross projected
Test
No active test
Last cross
Golden cross 28 Aug 2025 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $64.80 vs 50 $60.54 / 200 $47.03
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 7 Apr 2025 ยท projected 29 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $64.66 vs 50 $63.69 / 200 $67.00
Projection
No cross projected
Test
No active test
Last cross
Death cross 13 Oct 2026 ยท projected 24 bars out

Cross history

36
crosses on record since 2017
18 golden18 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
13 Oct 2026Death4-hour24 bars outNot tested
29 Apr 2026Golden4-hour30 bars outNot tested
30 Mar 2026Death4-hour30 bars out4 bar cross test
28 Aug 2025Golden steepdaily26 bars outNot tested
11 Jul 2025Golden4-hour5 bars outโ€”

About XPH

ExchangeAMEX
InstrumentETF
Median $ volume, 60 d$8.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.